'For
the quarter ending Sept 2023, consolidated Net sales (including other operating income) of Divis Laboratories has increased 2.91% to Rs 1909 crore compared to quarter ended Sept 2022.Operating profit margin has declined from 33.48% to 25.09%, leading to 22.87% decline in operating profit to Rs 479.00 crore. Raw material cost as a % of total sales (net of stock adjustments) decreased from 40.79% to 39.28%. Employee cost increased from 11.58% to 14.70%. Other expenses rose from 16.33% to 19.56%.
Other income rose 7.50% to Rs 86 crore. PBIDT fell 19.40% to Rs 565 crore. Provision for interest remained nil.
PBDT fell 19.54% to Rs 564 crore. Provision for depreciation rose 10.47% to Rs 95 crore.
Profit before tax down 23.74% to Rs 469.00 crore. Share of profit/loss were nil in both the periods. Provision for tax was expense of Rs ...
Pleaselogin & subscribe to view the full report.
More Reports
|
|